Clinical Trial Update: Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab combined with hyaluronidase in patients with advanced cutaneous melanoma receiving nivolumab and ipilimumab; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• Rituxan Hycela (rituximab/hyaluronidase)

Snippet

Sponsor: Emory University | Conditions: Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-22